Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks
Nature Communications · 21.11.2024 · 15 (1)
DOI: 10.1038/s41467-024-54357-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Communications, online erschienen am 21.11.2024. Verfasst von Nightingale Health Biobank Collaborative Group. Hauptthemen laut MEDLINE: Metabolomics, Biological Specimen Banks, Biomarkers. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Identifying individuals at high risk of chronic diseases via easily measured biomarkers could enhance efforts to prevent avoidable illness and death. Using 'omic data can stratify risk for many diseases simultaneously from a single measurement that captures multiple molecular predictors of risk. Here we present nuclear magnetic resonance metabolomics in blood samples from 700,217 participants in three national biobanks. We built metabolomic scores that identify high-risk groups for diseases that cause the most morbidity in high-income countries and show consistent cross-biobank replication of the relative risk of disease for these groups. We show that these metabolomic scores are more strongly associated with disease onset than polygenic scores for most of these diseases. In a subset of 18,709 individuals with metabolomic biomarkers measured at two time points we show that people whose scores change have different risk of disease, suggesting that repeat measurements capture changes both to health status and disease risk possibly due to treatment, lifestyle changes or other factors. Lastly, we assessed the incremental predictive value of metabolomic scores over existing clinical risk scores for multiple diseases and found modest improvements in discrimination for several diseases whose clinical utility, while promising, remains to be determined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Nightingale Health Biobank Collaborative Group (2024). Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-54357-0
Vancouver
Nightingale Health Biobank Collaborative Group. Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks. Nature Communications. 2024;15(1). doi:10.1038/s41467-024-54357-0
BibTeX
@article{NightingaleHealthBiobankCollaborativeGroup2024,
author = {Nightingale Health Biobank Collaborative Group, Nightingale Health Biobank Collaborative Group},
title = {Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks},
journal = {Nature Communications},
year = {2024},
volume = {15},
number = {1},
doi = {10.1038/s41467-024-54357-0}
}
EUVIMED